Investor Presentaiton

LOVVOLUS DURATION JEUVEAU EXTRA-STRENGTH PHASE II DURATION STUDY KAPLAN-MEIER: ≥1 PT IMPROVEMENT GLABELLAR LINE SCALE AT MAXIMUM FROWN Investigator assessment 100 80 PRA 40U VS. PRA 20U: HR 1.892, P-VALUE 0.0109 PRA 40U VS. ONA 20U: HR 2.38, P-VALUE 0.0002 De PERCENT OF PATIENTS (%) 60 40. 20 0 PRABOTULINUM ES 40U 183 (153, 211) DAYS, 26.1 WEEKS, 6.0 MONTHS PRABOTULINUM 20U 149 (130, 174) DAYS, 21.3 WEEKS, 4.9 MONTHS ONABOTULINUM 20U 148 (121, 174) DAYS, 21.1 WEEKS, 4.9 MONTHS 0 30 60 90 120 150 180 210 240 270 300 330 DAYS FROM TREATMENT 22 22

View entire presentation